Prediction of Amyloid Fibril-forming Proteins*

In Alzheimer's disease and spongiform encephalopathies proteins transform from their native states into fibrils. We find that several amyloid-forming proteins harbor an α-helix in a polypeptide segment that should form a β-strand according to secondary structure predictions. In 1324 nonredundant protein structures, 37 β-strands with ≥7 residues were predicted in segments where the experimentally determined structures show helices. These discordances include the prion protein (helix 2, positions 179–191), the Alzheimer amyloid β-peptide (Aβ, positions 16–23), and lung surfactant protein C (SP-C, positions 12–27). In addition, human coagulation factor XIII (positions 258–266), triacylglycerol lipase from Candida antarctica (positions 256–266), andd-alanyl-d-alanine transpeptidase fromStreptomyces R61 (positions 92–106) contain a discordant helix. These proteins have not been reported to form fibrils but in this study were found to form fibrils in buffered saline at pH 7.4. By replacing valines in the discordant helical part of SP-C with leucines, an α-helix is found experimentally and by secondary structure predictions. This analogue does not form fibrils under conditions where SP-C forms abundant fibrils. Likewise, when Aβ residues 14–23 are removed or changed to a nondiscordant sequence, fibrils are no longer formed. We propose that α-helix/β-strand-discordant stretches are associated with amyloid fibril formation.

[1]  P. Y. Chou,et al.  Prediction of the secondary structure of proteins from their amino acid sequence. , 2006 .

[2]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[3]  J M Ghuysen,et al.  2.8-A Structure of penicillin-sensitive D-alanyl carboxypeptidase-transpeptidase from Streptomyces R61 and complexes with beta-lactams. , 1986, The Journal of biological chemistry.

[4]  D. Lipman,et al.  Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Nolde,et al.  Three-dimensional structure of proteolytic fragment 163-231 of bacterioopsin determined from nuclear magnetic resonance data in solution. , 1992, European journal of biochemistry.

[6]  C. Barrow,et al.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.

[7]  R. Huber,et al.  Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases , 1992, Nature.

[8]  U. Hobohm,et al.  Selection of representative protein data sets , 1992, Protein science : a publication of the Protein Society.

[9]  L. Hood,et al.  Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.

[10]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Rost,et al.  Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.

[12]  B. Rost,et al.  Combining evolutionary information and neural networks to predict protein secondary structure , 1994, Proteins.

[13]  R. Abagyan,et al.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.

[14]  K. Wüthrich,et al.  The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich alpha-helix. , 1994, Biochemistry.

[15]  F. Cohen,et al.  Proposed three-dimensional structure for the cellular prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Lippard,et al.  Geometry of the soluble methane monooxygenase catalytic diiron center in two oxidation states. , 1995, Chemistry & biology.

[17]  K. Wüthrich,et al.  Pulmonary surfactant‐associated polypeptide SP‐C in lipid micelles: CD studies of intact SP‐C and NMR secondary structure determination of depalmitoyl‐SP‐C(1–17) , 1995, FEBS letters.

[18]  J. Johansson,et al.  Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C. , 1995, The Biochemical journal.

[19]  L. Tjernberg,et al.  Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.

[20]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[21]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[22]  R. Wetzel For Protein Misassembly, It's the “I” Decade , 1996, Cell.

[23]  F. Cohen,et al.  Physical studies of conformational plasticity in a recombinant prion protein. , 1997, Biochemistry.

[24]  F E Cohen,et al.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[26]  J. Cherfils,et al.  Structure of the Sec7 domain of the Arf exchange factor ARNO , 1998, Nature.

[27]  K. Wüthrich,et al.  Pulmonary surfactant‐associated polypeptide C in a mixed organic solvent transforms from a monomeric α‐helical state into insoluble β‐sheet aggregates , 1998, Protein science : a publication of the Protein Society.

[28]  I. Kurochkin Amyloidogenic determinant as a substrate recognition motif of insulin‐degrading enzyme , 1998, FEBS letters.

[29]  E. Meyer,et al.  Structures of adamalysin II with peptidic inhibitors. Implications for the design of tumor necrosis factor α convertase inhibitors , 1998, Protein science : a publication of the Protein Society.

[30]  J. W. Kelly The environmental dependency of protein folding best explains prion and amyloid diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Surewicz,et al.  Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.

[32]  I D Campbell,et al.  Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Riek,et al.  Prion protein structural features indicate possible relations to signal peptidases , 1998, FEBS letters.

[34]  J. Johansson,et al.  Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution. , 1998, European journal of biochemistry.

[35]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[36]  J. Thyberg,et al.  Amyloid fibril formation by pulmonary surfactant protein C , 1999, FEBS letters.

[37]  M. Hecht,et al.  De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Anne Lecroisey,et al.  The crystal structure of HasA, a hemophore secreted by Serratia marcescens , 1999, Nature Structural Biology.

[40]  P. Lansbury Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Glockshuber,et al.  Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.

[42]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[43]  Lars Terenius,et al.  A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation* , 1999, The Journal of Biological Chemistry.

[44]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[45]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[46]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Davis,et al.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.